HT
ONCT

HAP Trading’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

HAP Trading’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-560
Closed -$1K – 2471
2022
Q1 		$1K Buy
+560
New +$20.4K ﹤0.01% 2145
2021
Q4 		– Sell
-6,015
Closed -$17K – 2952
2021
Q3 		$17K Buy
6,015
+1,095
+22% +$90.6K ﹤0.01% 1856
2021
Q2 		$92K Buy
4,920
+4,390
+828% +$521K ﹤0.01% 1245
2021
Q1 		$20K Buy
+530
New +$70.1K ﹤0.01% 1464

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return